Erika M. Moore

Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness

Felix Geser, John Robinson, Joseph A. Malunda et al. · Archives of Neurology · 2010 · 108 citations · Full text

Life Sciences, Genetics, Psychiatry +15

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study

Heesun J. Rogers, J. W. Vardiman, John Anastasi et al. · Haematologica · 2014 · 83 citations · Full text

Medicine, Hematology, Oncology +17

Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid Morphology

Erika M. Moore, Nidhi Aggarwal, Urvashi Surti et al. · The American Journal of Surgical Pathology · 2017 · 45 citations

Medicine, Oncology, Pathology +17

Use of flow cytometry in the diagnosis of lymphoproliferative disorders in fluid specimens

Gordon H. Yu, Norge Vergara, Erika M. Moore et al. · Diagnostic Cytopathology · 2014 · 38 citations

Medicine, Hematology, Pathology +9

J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

Erika M. Moore, Steven H. Swerdlow, Sarah E. Gibson · Human Pathology · 2017 · 18 citations

Medicine, Oncology, Pathology +11